Aurobindo, Sandoz call off 900 million US dollar deal Medical Dialogues Bureau2 April 2020 3:27 PM ISTNew Delhi: Aurobindo Pharma on Thursday said the USD 900 million deal to acquire Sandoz Inc''s US-based generic oral solids and dermatology...
Sandoz commits to keep prices of essential medicines stable amidst coronavirus fear Medical Dialogues Bureau1 March 2020 10:00 AM ISTGermany: Sandoz the provider of off-patent antibiotic medicines worldwide, made a public commitment to ensure stable pricing for a basket of essential...
Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal Medical Dialogues Bureau26 Nov 2019 9:30 AM ISTIn September 2018, the USD three billion drug-maker, Aurobindo Pharma said its US subsidiary entered into an agreement to acquire commercial...
Carcinogen in popular heartburn drug Zantac triggers safety review by European, US regulators Medical Dialogues Bureau14 Sept 2019 9:15 AM ISTValisure said in its report that it found the impurity in both Sanofi SA's branded Zantac as well as generic versions of the drug. But the FDA would...
Novartis, Lonza strengthen biosimilars push with MS, arthritis drug deals Medical Dialogues Bureau3 Sept 2019 9:30 AM ISTNovartis's Sandoz generics unit, among the biggest biosimilars makers, on Tuesday, agreed to license from Poland's Polpharma Biologics a version of...
Novartis CEO Vas Narasimhan vows not to sell Sandoz generics unit Medical Dialogues Bureau29 July 2019 9:17 AM ISTNovartis is revamping Sandoz, a process Narasimhan has previously said will take roughly the next year and a half. He has already sold a generic U.S....
Sandoz launches SYMJEPI Injection in US to help treat allergic reactions Medical Dialogues Bureau13 July 2019 9:32 AM ISTSYMJEPI is a small, single-dose, pre-filled syringe and device combination as an alternative to epinephrine auto-injectors for the emergency treatment...
Sandoz, Kit Check collaborate to track, automate restocking of products in hospitals Farhat Nasim30 Jun 2019 9:12 AM ISTBy collaborating with Kit Check, Sandoz will be able to better understand how its medicines are used in hospitals, optimize the supply chain by...
Sun pharma, Dr Reddys, others deny allegations of price fixing in US Garima16 May 2019 9:35 AM ISTIn separate clarifications to stock exchanges, the companies including Glenmark, Sun Pharma, Dr Reddy's, Aurobindo Pharma denied the accusations and...
Inflated prices to 1000 per cent; Lupin, Sun Pharma, Dr Reddys, others face lawsuit Farhat Nasim14 May 2019 4:57 PM ISTMumbai: In a major setback, a group of domestic pharmaceutical companies including Zydus Cadila, Lupin, Aurobindo Pharma, Dr Reddy's Labs, Wockhardt,...
Sandoz to commercialize Rizmoic to treat opioid-induced constipation Farhat Nasim13 April 2019 9:21 AM ISTHOLZKIRCHEN: Sandoz recently announces that it has signed an agreement with Shionogi & Co Ltd for commercialization of Rizmoic (naldemedine) in...
Novartis division resubmits USFDA application for biosimilar Pegfilgrastim Farhat Nasim4 April 2019 9:15 AM ISTNew Delhi: Novartis division, Sandoz, recently announced resubmission of its Biologics License Application (BLA) for a proposed biosimilar...
